Literature DB >> 1322902

The vaccinia virus mRNA (guanine-N7-)-methyltransferase requires both subunits of the mRNA capping enzyme for activity.

M A Higman1, N Bourgeois, E G Niles.   

Abstract

Plasmid vectors capable of expressing the large and small subunits of the vaccinia virus mRNA capping enzyme were constructed and used to transform Escherichia coli. Conditions for the induction of the dimeric enzyme or the individual subunits in a soluble form were identified, and the capping enzyme was purified to near homogeneity. Proteolysis of the capping enzyme in bacteria yields a 60-kDa product shown previously to possess the mRNA triphosphatase and guanyltransferase activities (Shuman, S. (1990) J. Biol. Chem. 265, 11960-11966) was isolated and shown by amino acid sequence analysis to be derived from the NH2 terminus of D1R. The individual subunits lacked methyltransferase activity when assayed alone. However, mixing the D1R and D12L subunits permitted reconstitution of the methyltransferase activity, and this appearance in activity accompanied the association of the subunits. In contrast, mixing the D12L subunit with the D1R-60K proteolytic fragment failed to yield methyltransferase activity or result in a physical association of the two proteins. These results demonstrate that the methyltransferase active site requires the presence of the D12L subunit with the carboxyl-terminal portion of the D1R subunit. Furthermore, since the mRNA triphosphatase and guanyltransferase active sites reside in the NH2-terminal domain of the D1R subunit, and the methyltransferase activity is found in the carboxyl-terminal portion of this subunit and D12L, there must be at least two separate active sites in this enzyme.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322902

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Enzymology of RNA cap synthesis.

Authors:  Agnidipta Ghosh; Christopher D Lima
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-25       Impact factor: 9.957

2.  Structural insights into the mechanism and evolution of the vaccinia virus mRNA cap N7 methyl-transferase.

Authors:  Marcos De la Peña; Otto J P Kyrieleis; Stephen Cusack
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

3.  Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme.

Authors:  Amber N Shatzer; Sayuri E M Kato; Richard C Condit
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

4.  A cyclophilin functions in pre-mRNA splicing.

Authors:  David S Horowitz; Edward J Lee; Stephen A Mabon; Tom Misteli
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

5.  Crystal structure of vaccinia virus mRNA capping enzyme provides insights into the mechanism and evolution of the capping apparatus.

Authors:  Otto J P Kyrieleis; Jonathan Chang; Marcos de la Peña; Stewart Shuman; Stephen Cusack
Journal:  Structure       Date:  2014-03-04       Impact factor: 5.006

6.  Structure-function analysis of the triphosphatase component of vaccinia virus mRNA capping enzyme.

Authors:  L Yu; A Martins; L Deng; S Shuman
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Vaccinia virus early gene transcription termination factors VTF and Rap94 interact with the U9 termination motif in the nascent RNA in a transcription ternary complex.

Authors:  Linda A Christen; Sarah Piacente; Mohamed R Mohamed; Edward G Niles
Journal:  Virology       Date:  2008-05-01       Impact factor: 3.616

8.  Comparative whole genome sequence analysis of wild-type and cidofovir-resistant monkeypoxvirus.

Authors:  Jason Farlow; Mohamed Ait Ichou; John Huggins; Sofi Ibrahim
Journal:  Virol J       Date:  2010-05-28       Impact factor: 4.099

9.  Allosteric interactions between capping enzyme subunits and the RNA polymerase II carboxy-terminal domain.

Authors:  E J Cho; C R Rodriguez; T Takagi; S Buratowski
Journal:  Genes Dev       Date:  1998-11-15       Impact factor: 11.361

10.  Efficient preparation and properties of mRNAs containing a fluorescent cap analog: Anthraniloyl-m(7)GpppG.

Authors:  Dilantha Gunawardana; Artem V Domashevskiy; Ken R Gayler; Dixie J Goss
Journal:  Translation (Austin)       Date:  2015-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.